Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 6/20 | 0.73 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.68 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.68 |
| ▸ | F2 | P00734 | 4/20 | 0.64 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.62 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.62 |
| ▸ | CCKBR | P32239 | 2/20 | 0.61 |
| ▸ | GLP1R | P43220 | 2/20 | 0.61 |
| ▸ | EP300 | Q09472 | 1/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.59 |
| ▸ | NPY2R | P49146 | 2/20 | 0.57 |
| ▸ | NPY4R | P50391 | 2/20 | 0.57 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.57 |
| ▸ | NPY1R | P25929 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30658200 | 0.94 | CALCR (0.71) | CALCRHCRTR1HCRTR2F2CRHR1 | |
| SCHEMBL29599159 | 0.90 | CALCR (0.75) | CALCRHCRTR1HCRTR2F2CRHR1 | |
| SCHEMBL29903351 | 0.90 | CALCR (0.71) | CALCRHCRTR1HCRTR2F2CRHR1 | |
| SCHEMBL31000946 | 0.90 | CALCR (0.64) | CALCRHCRTR1HCRTR2F2CRHR1 | |
| SCHEMBL30432045 | 0.89 | CALCR (0.65) | CALCRHCRTR1HCRTR2F2CRHR1 | |
| SCHEMBL31182828 | 0.89 | CALCR (0.71) | CALCRHCRTR1HCRTR2F2CRHR1 | |
| SCHEMBL30648485 | 0.89 | CALCR (0.66) | CALCRHCRTR1HCRTR2F2CRHR1 | |
| SCHEMBL30712880 | 0.89 | CALCR (0.61) | CALCRHCRTR1HCRTR2F2CRHR1 | |
| SCHEMBL29812782 | 0.89 | CALCR (0.68) | CALCRHCRTR1HCRTR2F2CRHR1 | |
| SCHEMBL30432477 | 0.88 | CALCR (0.78) | CALCRHCRTR1HCRTR2F2CRHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11753627-B2 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-09-12 | — | — | US | disclosed |